» Articles » PMID: 61283

Equine Infectious Anemia Virus: Evidence Favoring Classification As a Retravirus

Overview
Journal J Virol
Date 1976 Sep 1
PMID 61283
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Equine infectious anemia virus (EIAV) has a density of 1.154 g/cm3 in sucrose a high-molecular-weight RNA similar in size to Rauscher murine leukemia virus, and an internal virion reverse transcriptase that utilizes the synthetic RNA template poly(rA) but not the synthetic DNA template poly(dA), both with (dT)12 as primer. Although capable of utilizing manganese at low concentrations (approximately 0.1 mM), EIAV reverse transcriptase showed highest activity in the presence of 9 mM magnesium. The major protein of EIAV has a slightly lower molecular weight than the comparable protein of type C viruses and co-electrophoresed with 125I-labeled p25 of Mason-Pfizer monkey virus. A reference horse serum with antibodies to the major EIAV protein reacted only with EIAV and not with other type C or non-type C retraviruses. Reciprocally, a broadly reactive serum to type C virus p30s and specific sera to a variety of non-type C retraviruses did not react with EIAV. We recommend the inclusion of EIAV in the family Retraviridae.

Citing Articles

Gene Therapy Applications of Non-Human Lentiviral Vectors.

Munis A Viruses. 2020; 12(10).

PMID: 33003635 PMC: 7599719. DOI: 10.3390/v12101106.


Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders.

Cavalieri V, Baiamonte E, Lo Iacono M Viruses. 2018; 10(6).

PMID: 29890733 PMC: 6024700. DOI: 10.3390/v10060316.


Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45.

Duan L, Du J, Liu X Protein Sci. 2015; 24(10):1549-59.

PMID: 26174372 PMC: 4594655. DOI: 10.1002/pro.2750.


Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty....

Chen Z, Telfier P, Gettie A, Reed P, Zhang L, Ho D J Virol. 1996; 70(6):3617-27.

PMID: 8648696 PMC: 190237. DOI: 10.1128/JVI.70.6.3617-3627.1996.


Pathogenesis of human immunodeficiency virus infection.

Levy J Microbiol Rev. 1993; 57(1):183-289.

PMID: 8464405 PMC: 372905. DOI: 10.1128/mr.57.1.183-289.1993.


References
1.
GREENWOOD F, Hunter W, GLOVER J . THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963; 89:114-23. PMC: 1202279. DOI: 10.1042/bj0890114. View

2.
Hunter R, Strickland F . Immunization with a lipid-conjugated membrane antigen to suppress growth of a fibrosarcoma induced by simian virus 40. J Natl Cancer Inst. 1975; 54(5):1157-63. DOI: 10.1093/jnci/54.5.1157. View

3.
Dalton A, HEINE U, Melnick J . Symposium: characterization of oncornaviruses and related viruses--a report. J Natl Cancer Inst. 1975; 55(4):941-3. DOI: 10.1093/jnci/55.4.941. View

4.
Charman H, Kim N, White M, Marquardt H, Gilden R, Kawakami T . Natural and experimentally induced antibodies to defined mammalian type-C virus proteins in primates. J Natl Cancer Inst. 1975; 55(6):1419-24. DOI: 10.1093/jnci/55.6.1419. View

5.
Charman H, Gardner M, McAllister R, Kim N, Gilden R . Humoral immune responses of cats to mammalian type-C virus p30s. Int J Cancer. 1976; 17(1):98-108. DOI: 10.1002/ijc.2910170114. View